Document Detail


Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery.
MedLine Citation:
PMID:  15968395     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We investigated the relationship between factor XIII, fibrinogen, blood coagulation screening tests and postoperative bleeding in 98 patients undergoing cardiopulmonary bypass (CPB) surgery. All patients received aprotinin. Blood samples were collected preoperatively (T1),after termination of CPB (T2),12 h (T3) and 24 h (T4) after surgery to determine FXIII activity, fibrinogen, platelet count, prothrombin time (PT), activated partial thromboplastin time (APTT) and D-dimers (DD). Laboratory results were correlated with the chest tube drainage 24 h after surgery and compared between patients with 24-hour chest tube drain volumes in the lower (Group 1) with those in the upper tertile (Group 3). Median FXIII and fibrinogen levels dropped by 33.9% and 34.2%, respectively, during CPB. No association between FXIII activity and the extent of postoperative bleeding was found. However, chest tube bleeding was significantly correlated with preoperative and postoperative fibrinogen. This was confirmed by comparing Groups 1 and 3. Group 3 patients had significantly lower fibrinogen levels than Group 1 at T1 - T4, although most fibrinogen values were within or above the reference range (medians, g/l: 3.5 vs. 4.0, p = 0.043 at T1; 2.3 vs. 2.7, p = 0.015 at T2; 2.9 vs. 3.3, p = 0.008 at T3; 4.2 vs. 5.2, p = 0.002 at T4). There was also a significant relationship of platelet count, PT and APTT, as measured after CPB (T2), with postoperative chest tube drainage. In conclusion, plasma FXIII activity does not influence postoperative bleeding in patients undergoing CPB surgery. There is however an inverse association between preoperative or postoperative plasma fibrinogen levels and postoperative bleeding. These findings indicate a modulation of postoperative bleeding by fibrinogen levels.
Authors:
Markus Blome; Frank Isgro; Arndt Holger Kiessling; Jan Skuras; Hannelore Haubelt; Peter Hellstern; Werner Saggau
Related Documents :
8523015 - Prospective randomized evaluation of blood salvage techniques for primary total hip art...
7708865 - Autologous blood use in reduction mammaplasty: is it justified?
10230955 - Effects of phentolamine on tissue perfusion in pediatric cardiac surgery.
7993195 - Oversaturation status of reticuloendothelial system following cardiopulmonary bypass.
9660255 - Oxygen tolerance in patients with acute respiratory failure.
24668355 - Non-arthroplasty treatment of osteoarthritis of the knee.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  93     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-06-21     Completed Date:  2005-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1101-7     Citation Subset:  IM    
Affiliation:
Clinic for Cardiac Surgery, Institute of Hemostaseology, Academic City Hospital, D-67063 Ludwigshafen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Coronary Artery Bypass / adverse effects*
Factor XIII / metabolism*
Female
Fibrinogen / metabolism*
Hemostasis
Humans
Male
Middle Aged
Postoperative Hemorrhage / blood*,  etiology*
Risk Factors
Time Factors
Chemical
Reg. No./Substance:
9001-32-5/Fibrinogen; 9013-56-3/Factor XIII

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population.
Next Document:  Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipi...